Olymvax

China
Chengdu, Sichuan, China

Company profile

Olymvax company profile

Olymvax is a biopharmaceutical firm that develops, manufactures, and sells human vaccinations. They are integrating global resources, maintaining cooperation with all parties, and striving to develop technological innovation for the development of vaccines. Their products include the tetanus vaccine and the Haemophilus influenzae B vaccine.

Business identity

Contact email
[email protected]
Phone number
86-28-69361111
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Founded
2009-12-11

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
1
Total equity funding
$8.7M
Last funding
Post IPO Equity / $8.7M / 2017-05-08
Last equity funding
Post IPO Equity / $8.7M
Articles
1
Exited on
2015-09-15

Founders and investors

No public relation records are available.